The Role of Occupational Therapy for Improving Medication Management for Persons With AMD, DR and Glaucoma

NCT06593405 | Recruiting Early Phase 1

• 1 other identifier: IRB-2023-2024-84
• Study Type: interventional
• Target: 50
• Locations: 1 country
• Sites: 1

Brief Summary

The goal of this clinical trial is to learn if education about additional task lighting, enhanced contrast, enlarged print instructions, smart apps and organizational strategies will improve medication management skills. The main questions it aims to answer are: Does additional task lighting, enhanced contrast, enlarged print instructions, smart apps and organizational strategies improve medication management skills, reduce errors and improve functional use of remaining vision for this task? Participants will: Oftentimes, the client is unaware of these strategies which may improve occupational performance during a valued activity. Clients with AMD, DR or Glaucoma who choose to receive the one hour OT service will be provided with 1:1 education regarding the devices and strategies that may improve their ability to perform medication management skills.

Conditions

Age-Related Macular Degeneration

Outcome Measures

Primary Outcomes (2)

• Revised Self Report Assessment of Functional Visual

  A standardized assessment which provides information on how well adults with vision loss can perform daily tasks. This tool has 33 assessment components and a higher score indicates less functional impairment. A lower score indicates a higher impairment.

  Results from the Revised-Self-Report Assessment of Functional Visual Performance assessment will be determined on day 1 and 4 weeks later

• MediCog Screening Tool

  The Medi-Cog has a maximum score of 10 points, and a score of 7 or lower may indicate cognitive impairment.

  Results from the MediCog will be determined on day 1 and will be obtained 4 weeks later

Study Arms (1)

Receiving OT interventions

EXPERIMENTAL

All participants will receive all OT interventions

Combination Product: occupational therapy interventions for low vision care

Interventions

occupational therapy interventions for low vision care COMBINATION_PRODUCT

Occupational therapists utilize many different treatment strategies when caring for the client with low vision. Oftentimes, the client is unaware of these strategies which may improve occupational performance during a valued activity. Interventions include task lighting, organizational strategies, smart apps, contrast, enlarged print, typoscopes and electronic magnification devices.

Receiving OT interventions

Eligibility Criteria

• Age: 50 Years - 100 Years
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Clients with AMD, DR or Glaucoma
• Clients who choose to participate will allow their deidentified data to be evaluated for outcomes.

You may not qualify if:

• Clients with other age related eye diseases other than AMD, DR or Glaucoma.
• Clients who do not wish to participate in this study.

Sponsors & Collaborators

• MCPHS University: lead

Study Sites (1)

MCPHS 10 Lincoln Square

Worcester, Massachusetts, 01608, United States

RECRUITING

Related Publications (1)

• Occupational Therapy's Role in Medication Management. Am J Occup Ther. 2017 Nov/Dec;71(Supplement_2):7112410025p1-7112410025p20. doi: 10.5014/ajot.2017.716S02. No abstract available.

  PMID: 29309002 BACKGROUND

Related Links

• American Occupational Therapy Association link to professional information

MeSH Terms

Conditions

Macular Degeneration

Condition Hierarchy (Ancestors)

Retinal Degeneration; Retinal Diseases; Eye Diseases

Study Officials

• Michelle Dowling, OTD

  MCPHS University

  PRINCIPAL INVESTIGATOR

Central Study Contacts

Michelle Dowling, OTD

CONTACT

508-373-5851; michelle.dowling@mcphs.edu

Study Design

• Study Type: interventional
• Phase: early phase 1
• Allocation: NA
• Masking: NONE
• Purpose: TREATMENT
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Model Details: This is a quasi-experimental study to determine outcomes with occupational therapy (OT) medication management interventions/strategies for persons with Age-related Macular Degeneration (AMD)

Study Record Dates

• First Submitted: August 26, 2024
• First Posted: September 19, 2024
• Study Start: April 22, 2025
• Primary Completion (Estimated): December 5, 2026
• Study Completion (Estimated): December 5, 2026
• Last Updated: September 29, 2025

Record last verified: 2025-04

Data Sharing

• IPD Sharing: Will share
• Shared Documents: STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
• Time Frame: 6 months after publication

Locations

US (1)